Lv1
92 积分 2026-04-14 加入
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors
10天前
已完结
Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6
10天前
已完结
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
10天前
已完结
Synthesis, characterization, crystal structures, and toxicity studies of nitro-lawsone, its oxime derivative, and Cu(II) complexes
20天前
已完结
p21-activated kinase 1 is allostericallyInhibited by naphthoquinone (NQ) derivatives
21天前
已完结
Back Pocket Flexibility Provides Group II p21-Activated Kinase (PAK) Selectivity for Type I 1/2 Kinase Inhibitors
1个月前
已完结
Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer Treatment
1个月前
已完结
Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?
3个月前
已关闭
The role and potential therapeutic application of HDAC6 inhibitors in inflammation-related diseases: A medicinal chemistry perspective
4个月前
已完结
Integrative function of histone deacetylase 3 in inflammation
4个月前
已完结
皖公网安备34019202002308
